CORC

在结果中检索

CORC

浏览/检索结果: 共44条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
ET White Paper: To Find the First Earth 2.0 预印本
2022
作者:  Ge, Jian;  Zhang, Hui;  Zang, Weicheng;  Deng, Hongping;  Mao, Shude
收藏  |  浏览/下载：40/0  |  提交时间：2022/07/29
The genome of Prunus humilis provides new insights to drought adaption and population diversity 期刊论文
DNA RESEARCH, 2022, 卷号: 29, 期号: 4
作者:  Wang, Yi;  Xie, Jun;  Zhang, Hongna;  Li, Weidong;  Wang, Zhanjun
收藏  |  浏览/下载：1/0  |  提交时间：2024/03/07
Predicting protein inter-residue contacts using composite likelihood maximization and deep learning (vol 20, 537, 2019) 期刊论文
BMC BIOINFORMATICS, 2019, 卷号: 20, 期号: 1, 页码: 5
作者:  Zhang, Haicang;  Zhang, Qi;  Ju, Fusong;  Zhu, Jianwei;  Gao, Yujuan
收藏  |  浏览/下载：51/0  |  提交时间：2020/12/10
Predicting protein inter-residue contacts using composite likelihood maximization and deep learning 期刊论文
BMC BIOINFORMATICS, 2019, 卷号: 20, 期号: 1, 页码: 11
作者:  Zhang, Haicang;  Zhang, Qi;  Ju, Fusong;  Zhu, Jianwei;  Gao, Yujuan
收藏  |  浏览/下载：50/0  |  提交时间：2020/12/10
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 期刊论文
JOURNAL OF HEPATOLOGY, 2019, 卷号: 70
作者:  Gong, Guozhong;  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun
收藏  |  浏览/下载：61/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  
收藏  |  浏览/下载：48/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：39/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：40/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：33/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：31/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace